SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-008130
Filing Date
2021-03-11
Accepted
2021-03-11 08:34:01
Documents
4
Period of Report
2021-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10021594x2_8k.htm 8-K 22252
2 EXHIBIT 1.1 nt10021594x2_ex1-1.htm EX-1.1 210666
3 EXHIBIT 5.1 nt10021594x2_ex5-1.htm EX-5.1 11096
4 nt10021594x2_ex5-1img01.jpg GRAPHIC 109196
  Complete submission text file 0001140361-21-008130.txt   395823
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 21731934
SIC: 2834 Pharmaceutical Preparations